The present invention relates generally to medical products and, more particularly, to devices that facilitate the identification of medical products under low-light or no-light conditions.
Medical products in kit form are typically carried by military personnel, law enforcement personnel, and rescue personnel or other first responders into emergency situations. The various products chosen for inclusion in the kit are generally those used to at least temporarily address a wound and to stabilize a patient until the patient can be transported to a medical facility. These products generally include bandages, gauze, and compounds such as iodine solutions or other ointments that may be applied to wounds to improve septic conditions. Other products may include smelling salts, salt tablets, and devices for the automatic injection of compounds to treat anaphylactic shock (such as an EPIPEN).
First aid, particularly in military scenarios, must often be administered in less than favorable conditions such as in low light or in the dark. It is often impractical to provide artificial lighting in such scenarios because lighting may be unavailable or may attract hostile attention to both the wounded person and the caregiver. Especially under battle conditions, even the use of pen-type flashlights or similar devices may be susceptible to undesirable detection.
Situations may also occur in which a person's vision is impaired so that he/she may not be able to open the medical kit. A person may also be blinded as a result of foreign objects such as dust, smoke, chemical vapors, blood, or the like in addition to direct injury to the eyes. In these types of situations, no amount of light would enable the blinded person to see sufficiently to self-administer the needed aid. Furthermore, unless a caregiver is adequately equipped with the necessary paraphernalia (respirators or masks) to counter the effects of dust, smoke, chemical vapors, etc., the caregiver is also unlikely to be able to access the medical kit and the contents therein.
There is a current need for an improved manner of identifying emergency medical products under less than adequate lighting conditions or in situations in which vision is impaired.
Based on the foregoing, it is a general object of the present invention to provide devices that facilitate the identification of medical products under low-light or no-light conditions to allow for the application of such products to wounded personnel.
Disclosed herein are devices that facilitate the identification of medical products under low-light or no-light conditions. Such conditions may be encountered in battle situations, in covert operations for purposes relating to reconnaissance or personnel and/or equipment transport, or as a result of climatic or environmental situations. The present invention is not limited in this regard, however, as other uses for the disclosed devices are within the scope of the invention. For example, the devices disclosed herein may also be utilized in conjunction with ammunition holders, communications apparatuses, tools, and the like.
In one aspect, the present invention resides in a pouch in which components of a medical kit are carried, the pouch being identifiable by means other than by the naked eye. The pouch is preferably closable using snaps, hook and loop material, zippers, or the like. The means for identification is attached to or integral with the pouch and may comprise raised and lowered surfaces that can be read by touch; serrations disposed on an edge or surface; a fluorescent coating viewable under infrared or ultraviolet light; or a pattern that is viewable using a thermal imaging device such as night vision goggles.
In another aspect, the present invention resides in a device for the identification of a medical item. The device is attachable to the medical item or to the packaging incorporating the item and includes a substrate and an arrangement of raised and lowered surfaces disposed thereon. The raised and lowered surfaces, which may be ridges, grooves, pimples, dimples, holes, Braille, or combinations thereof, define a pattern that is tactilely recognizable by a user when the user touches the raised and lowered surfaces.
In another aspect, the present invention resides in a device for the selective visual identification of a medical item. The device is attachable to the medical item and includes a substrate and a fluorescent ink disposed thereon. The fluorescent ink is visible under one of infrared light and ultraviolet light and is disposed on the substrate in a recognizable pattern (e.g., a medical cross).
In another aspect, the present invention resides in a device for the identification of a medical item, the device being attachable to the medical item. The device includes a substrate and a coating disposed thereon. The substrate is defined by a material having a first specific heat capacity, and the coating is defined by a material having a second specific heat capacity. The coating is disposed on the substrate in a recognizable pattern. The two specific heat capacities are different, which thereby allows one to be recognized relative to the other when viewed through a thermal imaging apparatus such as night vision goggles.
In another aspect, the present invention resides in a package for retaining a medical item. The package includes an identifying element of a material that is selectively viewable in response to light attributes of the material. The material is arranged to identify the contents of the package via lettering, colorings, graphics, combinations of the foregoing, and the like.
In another aspect, the present invention resides in a medical device that includes a hemostatic agent; a package in which the hemostatic agent is retained; and an identifying element on the package. The identifying element includes a material that is visually discernible in reduced light environments.
In another aspect, the present invention resides in a device for the visual identification of a package containing a medical item. Such a device includes an identifying element comprising a material that is visually discernible in reduced-light environments via the use of night vision devices. The identifying element may be formed into an indicia that indicates the contents of the package.
One advantage of the present invention is that a medical device can be utilized under hostile conditions without drawing unwanted attention. More specifically, by relying on tactile senses or the use of optical devices (such as those emitting infrared or ultraviolet light or those capable of reading thermal infrared radiation), a medical device can be found, opened, and applied as necessary for the treatment of a wound without compromising the position of the user.
Another advantage is that a medical device can be utilized under conditions in which the user is blinded. Rescue personnel, as well as law enforcement and military personnel, can rely on tactile abilities to locate specific items or to distinguish types of items for application in emergency situations such as heavy smoke, dust storms, and the like.
As shown in
Referring specifically to
Referring to both
Referring now to
Referring now to
In addition to being visible with the naked eye under ambient light conditions, the identifying element 30 includes attributes that allow it to be visually discerned with the naked eye in low-light or no-light environments. Such attributes may be embodied in materials that include, but are not limited to, photoluminescent materials (e.g., an ink 36 or other material). The photoluminescent materials for use with the present invention include, but are not limited to, phosphorescent materials; fluorescent materials; paints, inks, or dyes that emit light when subjected to blacklight; chemical sources such as phenyl oxylate esters; combinations of the foregoing; and the like. Phosphorescent material is particularly useful for devices that are not intended to be used in situations that require stealth (e.g., civilian paramedic and rescue situations).
Also the ink 36 or other material may include a material that is visible under infrared or ultraviolet light or a material that allows the identifying element to be viewed in partial or complete darkness using night observation devices or night vision devices, e.g., night vision goggles and/or night vision monoculars. Passive night vision devices (those which pick up any light in the immediate area and amplify it thereby allowing it to be seen) are preferred over active night vision devices (those which project infrared light and produce an image from the light reflected back). The material may be photoluminescent or it may comprise paints, inks, or dyes of a particular color that facilitates the viewing of the material through night observation devices or night vision devices.
Identifying indicia such as text or other markings may be part of the identifying element 30. For example, a cross 38 or similar recognizable pattern may be superimposed on the ink 36 or material (or the ink or material may be superimposed on the cross) to allow a person to view the identifying element 30 under normal lighting or in low-light or complete darkness.
Referring to
Referring back to
One of the components that make up the kit 10 may be a blood clotting agent in particle, granule, or powder form for application to a bleeding wound. Such a blood clotting agent is generally zeolite-based, although other types of blood clotting agents are within the scope of the present invention.
Referring now to
Referring now to
Although this invention has been shown and described with respect to the detailed embodiments thereof, it will be understood by those of skill in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the invention. In addition, modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from the essential scope thereof. Therefore, it is intended that the invention not be limited to the particular embodiments disclosed in the above detailed description, but that the invention will include all embodiments falling within the scope of the appended claims.
This application claims the benefit of U.S. Provisional Patent Application No. 60/796,121, filed on Apr. 27, 2006, the contents of which are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
2688586 | Eberl et al. | Sep 1954 | A |
2969145 | Hannauer, Jr. | Jan 1961 | A |
3122140 | Crowe et al. | Feb 1964 | A |
3181231 | Breck | May 1965 | A |
3189227 | Hobbs et al. | Jun 1965 | A |
3366578 | Michalko | Jan 1968 | A |
3386802 | Michalko | Jun 1968 | A |
3538508 | Young | Nov 1970 | A |
3550593 | Kaufman | Dec 1970 | A |
3658984 | Kamp | Apr 1972 | A |
3698392 | Vogt et al. | Oct 1972 | A |
3723352 | Warner et al. | Mar 1973 | A |
3763900 | Solms-Baruth et al. | Oct 1973 | A |
3979335 | Golovko et al. | Sep 1976 | A |
4373519 | Errede et al. | Feb 1983 | A |
4374044 | Schaefer et al. | Feb 1983 | A |
4379143 | Sherry et al. | Apr 1983 | A |
4435512 | Ito et al. | Mar 1984 | A |
4460642 | Errede et al. | Jul 1984 | A |
4514510 | Alexander | Apr 1985 | A |
4524064 | Nambu | Jun 1985 | A |
4525410 | Hagiwara et al. | Jun 1985 | A |
4569343 | Kimura et al. | Feb 1986 | A |
4626550 | Hertzenberg | Dec 1986 | A |
4631845 | Samuel et al. | Dec 1986 | A |
4651725 | Kifune et al. | Mar 1987 | A |
4717735 | Stem | Jan 1988 | A |
4728323 | Matson | Mar 1988 | A |
4748978 | Kamp | Jun 1988 | A |
4822349 | Hursey et al. | Apr 1989 | A |
4828081 | Nordstrom et al. | May 1989 | A |
4828832 | DeCuellar et al. | May 1989 | A |
4911898 | Hagiwara et al. | Mar 1990 | A |
4938958 | Niira et al. | Jul 1990 | A |
4956350 | Mosbey | Sep 1990 | A |
5140949 | Chu et al. | Aug 1992 | A |
5146932 | McCabe | Sep 1992 | A |
5474545 | Chikazawa | Dec 1995 | A |
5486195 | Meyers et al. | Jan 1996 | A |
5502042 | Gruskin et al. | Mar 1996 | A |
5538500 | Peterson | Jul 1996 | A |
5556699 | Nira et al. | Sep 1996 | A |
5578022 | Scherson et al. | Nov 1996 | A |
5597581 | Kaessmann et al. | Jan 1997 | A |
5599578 | Butland | Feb 1997 | A |
D386002 | Hinkle | Nov 1997 | S |
5696101 | Wu et al. | Dec 1997 | A |
5716337 | McCabe et al. | Feb 1998 | A |
5725551 | Meyers et al. | Mar 1998 | A |
5728451 | Langley et al. | Mar 1998 | A |
5766715 | Garconnet | Jun 1998 | A |
5788682 | Maget | Aug 1998 | A |
5801116 | Cottrell et al. | Sep 1998 | A |
5826543 | Raymond et al. | Oct 1998 | A |
5855570 | Scherson et al. | Jan 1999 | A |
5916511 | Kotani et al. | Jun 1999 | A |
5941897 | Meyers | Aug 1999 | A |
5964239 | Loux et al. | Oct 1999 | A |
5964349 | Odagiri | Oct 1999 | A |
5981052 | Sugiyama | Nov 1999 | A |
5993964 | Nakajima | Nov 1999 | A |
6037280 | Edwards et al. | Mar 2000 | A |
6060461 | Drake | May 2000 | A |
6086970 | Ren | Jul 2000 | A |
6123925 | Barry et al. | Sep 2000 | A |
6159232 | Nowakowski | Dec 2000 | A |
6187347 | Patterson et al. | Feb 2001 | B1 |
6203512 | Farris et al. | Mar 2001 | B1 |
6251423 | Bradford | Jun 2001 | B1 |
6372333 | Sugiyama et al. | Apr 2002 | B1 |
6428800 | Greenspan et al. | Aug 2002 | B2 |
6450537 | Norris | Sep 2002 | B2 |
6475470 | Kayane et al. | Nov 2002 | B1 |
6481134 | Aledo | Nov 2002 | B1 |
6486285 | Fujita | Nov 2002 | B2 |
6495367 | Isogawa et al. | Dec 2002 | B1 |
6523778 | Key et al. | Feb 2003 | B2 |
6573419 | Naimer | Jun 2003 | B2 |
6590337 | Nishikawa et al. | Jul 2003 | B1 |
6622856 | Gallo et al. | Sep 2003 | B2 |
6630140 | Grunstein | Oct 2003 | B1 |
6685227 | Merry et al. | Feb 2004 | B2 |
6700032 | Gray | Mar 2004 | B1 |
6701649 | Brosi | Mar 2004 | B1 |
6745720 | Rasner et al. | Jun 2004 | B2 |
6890177 | Dragan | May 2005 | B2 |
6998510 | Buckman et al. | Feb 2006 | B2 |
7125821 | Xu et al. | Oct 2006 | B2 |
7303759 | Mershon | Dec 2007 | B2 |
7371403 | McCarthy et al. | May 2008 | B2 |
7429252 | Sarangapani | Sep 2008 | B2 |
7595429 | Hursey | Sep 2009 | B2 |
7604819 | Huey et al. | Oct 2009 | B2 |
7825133 | Yi | Nov 2010 | B2 |
7858123 | Stucky | Dec 2010 | B2 |
7968114 | Huey et al. | Jun 2011 | B2 |
8063264 | Spearman et al. | Nov 2011 | B2 |
8114433 | Huey et al. | Feb 2012 | B2 |
8202532 | Huey et al. | Jun 2012 | B2 |
8252318 | Huey et al. | Aug 2012 | B2 |
8252344 | Hursey | Aug 2012 | B2 |
8257731 | Horn et al. | Sep 2012 | B2 |
8257732 | Huey et al. | Sep 2012 | B2 |
8277837 | Fischer et al. | Oct 2012 | B2 |
8383148 | Huey et al. | Feb 2013 | B2 |
8460699 | Huey et al. | Jun 2013 | B2 |
8512743 | Horn et al. | Aug 2013 | B2 |
20020077653 | Hudson et al. | Jun 2002 | A1 |
20020197302 | Cochrum et al. | Dec 2002 | A1 |
20030018357 | Luthra et al. | Jan 2003 | A1 |
20030133990 | Hursey et al. | Jul 2003 | A1 |
20030175333 | Shefer et al. | Sep 2003 | A1 |
20030176828 | Buckman et al. | Sep 2003 | A1 |
20030199922 | Buckman | Oct 2003 | A1 |
20030208150 | Bruder et al. | Nov 2003 | A1 |
20030212357 | Pace | Nov 2003 | A1 |
20040005350 | Looney et al. | Jan 2004 | A1 |
20040013715 | Wnek et al. | Jan 2004 | A1 |
20040038893 | Ladner et al. | Feb 2004 | A1 |
20040121438 | Quirk | Jun 2004 | A1 |
20040131820 | Turner et al. | Jul 2004 | A1 |
20040166172 | Rosati et al. | Aug 2004 | A1 |
20040166758 | Reichmann et al. | Aug 2004 | A1 |
20040169033 | Kuibira et al. | Sep 2004 | A1 |
20040243043 | McCarthy et al. | Dec 2004 | A1 |
20050023956 | Kwak et al. | Feb 2005 | A1 |
20050058721 | Hursey | Mar 2005 | A1 |
20050070693 | Hansen et al. | Mar 2005 | A1 |
20050074505 | Hursey | Apr 2005 | A1 |
20050107826 | Zhu et al. | May 2005 | A1 |
20050118230 | Hill et al. | Jun 2005 | A1 |
20050119112 | Pfenninger et al. | Jun 2005 | A1 |
20050137512 | Campbell et al. | Jun 2005 | A1 |
20050143689 | Ramsey, III | Jun 2005 | A1 |
20050147656 | McCarthy et al. | Jul 2005 | A1 |
20050246009 | Toner et al. | Nov 2005 | A1 |
20050248270 | Ghosh et al. | Nov 2005 | A1 |
20050249899 | Bonutti | Nov 2005 | A1 |
20060034935 | Pronovost et al. | Feb 2006 | A1 |
20060078628 | Koman et al. | Apr 2006 | A1 |
20060116635 | Van Heugten | Jun 2006 | A1 |
20060121101 | Ladizinsky | Jun 2006 | A1 |
20060141018 | Cochrum et al. | Jun 2006 | A1 |
20060141060 | Hursey et al. | Jun 2006 | A1 |
20060159733 | Pendharkar et al. | Jul 2006 | A1 |
20060172000 | Cullen et al. | Aug 2006 | A1 |
20060178609 | Horn et al. | Aug 2006 | A1 |
20060193905 | Ehringer et al. | Aug 2006 | A1 |
20060211965 | Horn et al. | Sep 2006 | A1 |
20060211971 | Horn et al. | Sep 2006 | A1 |
20060271094 | Hudson et al. | Nov 2006 | A1 |
20060282046 | Horn et al. | Dec 2006 | A1 |
20070016152 | Karpowicz et al. | Jan 2007 | A1 |
20070031515 | Stucky et al. | Feb 2007 | A1 |
20070065491 | Huey et al. | Mar 2007 | A1 |
20070104768 | Huey et al. | May 2007 | A1 |
20070104792 | Jenkins | May 2007 | A1 |
20070134293 | Huey et al. | Jun 2007 | A1 |
20070142783 | Huey et al. | Jun 2007 | A1 |
20070154509 | Wilcher et al. | Jul 2007 | A1 |
20070154510 | Wilcher et al. | Jul 2007 | A1 |
20070154564 | Stucky et al. | Jul 2007 | A1 |
20070160638 | Mentkow et al. | Jul 2007 | A1 |
20070160653 | Fischer et al. | Jul 2007 | A1 |
20070167971 | Huey et al. | Jul 2007 | A1 |
20070251849 | Lo et al. | Nov 2007 | A1 |
20070275073 | Huey et al. | Nov 2007 | A1 |
20070276308 | Huey et al. | Nov 2007 | A1 |
20070276345 | Huey et al. | Nov 2007 | A1 |
20070281011 | Jenkins et al. | Dec 2007 | A1 |
20080027365 | Huey | Jan 2008 | A1 |
20080085300 | Huey et al. | Apr 2008 | A1 |
20080097271 | Lo et al. | Apr 2008 | A1 |
20080125686 | Lo | May 2008 | A1 |
20080146984 | Campbell et al. | Jun 2008 | A1 |
20080199539 | Baker et al. | Aug 2008 | A1 |
20080206134 | Lo et al. | Aug 2008 | A1 |
20080254146 | Huey et al. | Oct 2008 | A1 |
20080254147 | Huey et al. | Oct 2008 | A1 |
20080269658 | Vinton et al. | Oct 2008 | A1 |
20080299226 | Mentkow et al. | Dec 2008 | A1 |
20080317831 | Lo | Dec 2008 | A1 |
20080319476 | Ward et al. | Dec 2008 | A1 |
20090008261 | Kotzeva et al. | Jan 2009 | A1 |
20090011394 | Meglan et al. | Jan 2009 | A1 |
20090018479 | McCarthy et al. | Jan 2009 | A1 |
20090043268 | Eddy et al. | Feb 2009 | A1 |
20090047366 | Bedard et al. | Feb 2009 | A1 |
20090053288 | Eskridge, Jr. et al. | Feb 2009 | A1 |
20090074880 | Ladizinsky | Mar 2009 | A1 |
20090076475 | Ross et al. | Mar 2009 | A1 |
20090112170 | Wells et al. | Apr 2009 | A1 |
20090123525 | Bedard | May 2009 | A1 |
20090162406 | Basadonna et al. | Jun 2009 | A1 |
20090186013 | Stucky | Jul 2009 | A1 |
20090186071 | Huey et al. | Jul 2009 | A1 |
20090232902 | Liu et al. | Sep 2009 | A1 |
20090274769 | Fregonese | Nov 2009 | A1 |
20090299253 | Hursey | Dec 2009 | A1 |
20100035045 | McAmish | Feb 2010 | A1 |
20100121244 | Horn et al. | May 2010 | A1 |
20100184348 | McAmish | Jul 2010 | A1 |
20100209531 | Stucky et al. | Aug 2010 | A2 |
20100228174 | Huey | Sep 2010 | A1 |
20100233248 | Huey et al. | Sep 2010 | A1 |
20110015565 | Hursey | Jan 2011 | A1 |
20110059287 | McAmish | Mar 2011 | A1 |
20110064785 | Daniels et al. | Mar 2011 | A1 |
20110150973 | Bowlin et al. | Jun 2011 | A1 |
20110229849 | Maurer et al. | Sep 2011 | A1 |
20110237994 | Russ et al. | Sep 2011 | A1 |
20110268784 | Huey | Nov 2011 | A1 |
20120004636 | Lo | Jan 2012 | A1 |
20120070470 | Pahari | Mar 2012 | A1 |
20120130296 | Huey | May 2012 | A1 |
20120259262 | Huey | Oct 2012 | A1 |
20130041332 | Huey | Feb 2013 | A1 |
20130079695 | Huey | Mar 2013 | A1 |
20130178778 | Huey | Jul 2013 | A1 |
20130344131 | Lo | Dec 2013 | A1 |
Number | Date | Country |
---|---|---|
1223208 | Jun 1987 | CA |
1970090 | May 2007 | CN |
101104080 | Jan 2008 | CN |
1114984 | Mar 2008 | CN |
101541274 | Sep 2009 | CN |
101687056 | Mar 2010 | CN |
0 107 051 | Sep 1983 | EP |
0 296 324 | Dec 1988 | EP |
0296324 | Dec 1988 | EP |
0 353 710 | Feb 1990 | EP |
0826822 | Mar 1998 | EP |
0888783 | Jul 1999 | EP |
1159972 | May 2001 | EP |
1 663 090 | Jun 2006 | EP |
1690553 | Aug 2006 | EP |
1714642 | Oct 2006 | EP |
1 810 697 | Jul 2007 | EP |
1810697 | Jul 2007 | EP |
1 679 087 | Jan 2010 | EP |
2 142 220 | Jan 2010 | EP |
1 667 623 | Nov 2010 | EP |
2 077 811 | Nov 2010 | EP |
2 292 196 | Mar 2011 | EP |
2 259 858 | Mar 1993 | GB |
2314842 | Jan 1998 | GB |
2 462 228 | Feb 2010 | GB |
1135892 | Jun 2010 | HK |
7088DELNP2009 | Apr 2008 | IN |
241410 | Jul 2010 | IN |
S59-62050 | Sep 1984 | JP |
61145120 | Jul 1986 | JP |
01-096558 | Oct 1987 | JP |
2-45040 | Feb 1990 | JP |
9-504719 | May 1997 | JP |
2777279 | Jul 1998 | JP |
10-337302 | Dec 1998 | JP |
11-071228 | Mar 1999 | JP |
11-178912 | Jul 1999 | JP |
11-332909 | Jul 1999 | JP |
2002-530157 | Sep 2002 | JP |
2002-331024 | Nov 2002 | JP |
2003-66045 | Mar 2003 | JP |
2003-305079 | Oct 2003 | JP |
2005-015537 | Jan 2005 | JP |
2004123651 | Jul 2006 | JP |
2011 00164 | Sep 2004 | TR |
WO 9505445 | Feb 1995 | WO |
WO 9512371 | May 1995 | WO |
WO 9640285 | Dec 1996 | WO |
WO 9913918 | Mar 1999 | WO |
WO 0030694 | Jun 2000 | WO |
WO 0066086 | Nov 2000 | WO |
WO 0182896 | Aug 2001 | WO |
WO 0197826 | Dec 2001 | WO |
WO 0230479 | Apr 2002 | WO |
WO 0230479 | Apr 2002 | WO |
WO 02060367 | Aug 2002 | WO |
WO 02074325 | Sep 2002 | WO |
WO 03074566 | Sep 2003 | WO |
WO 2005012493 | Feb 2005 | WO |
WO 2005027808 | Mar 2005 | WO |
WO 2005030279 | Apr 2005 | WO |
WO 2005087280 | Sep 2005 | WO |
WO 2005123170 | Dec 2005 | WO |
WO 2006006140 | Jan 2006 | WO |
WO 2006012218 | Feb 2006 | WO |
WO 2006086557 | Aug 2006 | WO |
WO 2006088912 | Aug 2006 | WO |
WO 2006102008 | Sep 2006 | WO |
WO 2006110393 | Oct 2006 | WO |
WO 2007120342 | Oct 2007 | WO |
WO 2008036225 | Mar 2008 | WO |
WO 2008054566 | May 2008 | WO |
WO 2008109160 | Sep 2008 | WO |
WO 2008127497 | Oct 2008 | WO |
WO 2008128149 | Oct 2008 | WO |
WO 2008136806 | Nov 2008 | WO |
WO 2008157536 | Dec 2008 | WO |
WO 2009032884 | Mar 2009 | WO |
WO 2009109194 | Sep 2009 | WO |
WO 2009126917 | Oct 2009 | WO |
Entry |
---|
Co-pending U.S. Appl. No. 10/939,687, filed Sep. 13, 2004. |
Co-pending U.S. Appl. No. 10/939,869, filed Sep. 13, 2004. |
Co-pending U.S. Appl. No. 11/023,869, filed Dec. 27, 2004. |
Co-pending U.S. Appl. No. 11/054,918, filed Feb. 9, 2005. |
Co-pending U.S. Appl. No. 11/082,716, filed Mar. 16, 2005. |
Co-pending U.S. Appl. No. 11/303,607, filed Dec. 16, 2005. |
Co-pending U.S. Appl. No. 11/404,126, filed Apr. 13, 2006. |
Co-pending U.S. Appl. No. 11/544,238, filed Oct. 6, 2006. |
Co-pending U.S. Appl. No. 11/584,079, filed Oct. 20, 2006. |
Co-pending U.S. Appl. No. 11/586,968, filed Oct. 25, 2006. |
Co-pending U.S. Appl. No. 11/590,427, filed Oct. 30, 2006. |
Co-pending U.S. Appl. No. 11/592,477, filed Nov. 2, 2006. |
Co-pending U.S. Appl. No. 11/606,617, filed Nov. 29, 2006. |
Co-pending U.S. Appl. No. 11/633,687, filed Dec. 4, 2006. |
Co-pending U.S. Appl. No. 11/634,673, filed Dec. 5, 2006. |
Co-pending U.S. Appl. No. 11/654,409, filed Jan. 17, 2007. |
Co-pending U.S. Appl. No. 11/710,106, filed Feb. 22, 2007. |
Co-pending U.S. Appl. No. 11/715,057, filed Mar. 6, 2007. |
Co-pending U.S. Appl. No. 12/101,336, filed Apr. 11, 2008. |
Co-pending U.S. Appl. No. 12/101,346, filed Apr. 11, 2008. |
Co-pending U.S. Appl. No. 12/140,356, filed Jun. 17, 2008. |
Co-pending U.S. Appl. No. 12/204,129, filed Sep. 4, 2008. |
U.S. Appl. No. 60/668,022, filed Apr. 4, 2005. |
U.S. Appl. No. 60/708,206, filed Aug. 15, 2005. |
U.S. Appl. No. 60/902,738, filed Feb. 21, 2007. |
U.S. Appl. No. 60/955,854, filed Aug. 14, 2007. |
U.S. Appl. No. 12/352,513, filed Jan. 12, 2009. |
PCT Search Report for PCT/US2004/29809, dated Feb. 24, 2005. |
International Search Report for Application No. PCT/US2004/029812, dated Jun. 14, 2005. |
European Search Report for Application No. 05445078 dated Jun. 27, 2006. |
Search Report for EP 05020602, dated Jul. 6, 2006. |
PCT Search Report for PCT/US2005/046700, dated Jul. 6, 2006. |
International Search Report for Application No. PCT/US2006/012487, dated Sep. 12, 2006. |
International Search Report for Application No. PCT/US2006/004594, dated Nov. 3, 2006. |
Search report for EP 06126082, dated May 11, 2007. |
Supplementary Partial European Search Report for Application No. EP04783867 dated Jan. 29, 2008. |
International Search Report for Application No. PCT/US2007/016509, dated Feb. 8, 2008. |
International Search Report for EP 06123557, dated Feb. 29, 2008. |
International Search Report for Application No. PCT/US2008/075191, dated Nov. 17, 2008. |
Donald Voet & Judith Voet, “Molecular Physiology”, Biochemistry, p. 1087-1096, vol. 64, 1990, John Wiley & Sons. |
Ima-Eu, Kaolin, Oct. 2006, p. 1-2. |
The Merck Index; 1989, pp. 1596-1597, abstract 10021. |
Hursey, et al., Bandage Using Molecular Sieves, Apr. 18, 2002, International Application Published Under the PCT, WO 02/30479 A1. |
Alam, et al., Comparative Analysis of Hemostatic Agents in a Swine Model of Lethal Groin Injury, Jun. 2003, The Journal of Trauma Injury, Infection, and Critical Care, vol. 54, No. 6, pp. 1077-1082. |
M. Gielen, Solid State Organometallic Chemistry: Methods and Applications Physical Organometallic Chemistry, 1999, New York John Wiley & Sons, Ltd. (UK), V. 2, p. 156. |
Le Van Mao, Raymond et al. “Mesporous Aluminosilicates prepared from Zeolites by Treatment with Ammonium Fluorosilicate.” J. Mater. Chem. 1993. pp. 679-683, vol. 3, No. 6. |
Dyer, A. et al. “Diffusion in heteroionic zeolites: Part 1. Diffusion of water in heteroionics natrolites.” Microporous and Mesoporous Materials. 1998, pp. 27-38, vol. 21. |
Wright, J.K. et al., “Thermal Injury Resulting from Application of a Granular Mineral Hemostatic Agent.” The Journal of Trauma Injury, Infection, and Critical Care. 2004, pp. 224-230, vol. 57, No. 2. |
Top, Ayben et al. “Silver, zinc, and copper exchange in a Na-clinoptilolite and resulting effect on antibacterial activity.” Applied Clay Science. 2004, pp. 13-19, vol. 27. |
Office Action for U.S. Appl. No. 11/398,161 dated Apr. 30, 2008. |
U.S. Appl. No. 10/939,687, filed Sep. 13, 2004 including prosecution history, including but not limited to Non-Final Rejection dated Oct. 16, 2006, Final Rejection dated May 24, 2007, Non-Final Rejection dated Sep. 6, 2007, Final Rejection dated Nov. 28, 2007 and Examiner's Answer to Appeal Brief. |
U.S. Appl. No. 10/939,869, filed Sep. 13, 2004 including prosecution history, including but not limited to Non-Final Rejection dated Feb. 8, 2008, Non-Final Rejection dated Sep. 17, 2008 and Final Rejection dated Apr. 17, 2009. |
U.S. Appl. No. 11/023,869, filed Dec. 27, 2004 including prosecution history, including but not limited to Requirement for Restriction/Election dated Mar. 31, 2008, Non-Final Rejection dated May 12, 2008 and Non-Final Rejection dated Dec. 11, 2008. |
U.S. Appl. No. 11/054,918, filed Feb. 9, 2005 including prosecution history, including but not limited to Non-Final Office Rejection dated Mar. 18, 2008, Final Rejection dated Sep. 16, 2008 and Non-Final Rejection dated Mar. 9, 2009. |
U.S. Appl. No. 11/082,716, filed Mar. 16, 2005 including prosecution history, including but not limited to Non-Final Rejection dated Oct. 9, 2008. |
U.S. Appl. No. 11/303,607, filed Dec. 16, 2005 including prosecution history, including but not limited to Requirement for Restriction/Election dated Feb. 21, 2008, Non-Final Rejection dated Apr. 29, 2008 and Non-Final Rejection dated Sep. 8, 2008. |
U.S. Appl. No. 11/404,126, filed Apr. 13, 2006 including prosecution history, including but not limited to Requirement for Restriction/Election dated Sep. 16, 2008 and Non-Final Rejection dated Dec. 3, 2008. |
U.S. Appl. No. 11/544,238, filed Oct. 6, 2006 including prosecution history, including but not limited to Requirement for Restriction/Election dated Dec. 11, 2008; Non-Final Office Action dated May 29, 2009. |
U.S. Appl. No. 11/584,079, filed Oct. 20, 2006 including prosecution history, including but not limited to Non-Final Rejection dated Apr. 6, 2009. |
U.S. Appl. No. 11/590,427, filed Oct. 30, 2006 including prosecution history, including but not limited to Non-Final Rejection dated Aug. 19, 2008 and Final Rejection dated May 26, 2009. |
U.S. Appl. No. 11/592,477, filed Nov. 2, 2006 including prosecution history, including but not limited to Non-Final Rejection dated May 28, 2008 and Final Rejection dated Dec. 22, 2008. |
U.S. Appl. No. 11/633,687, filed Dec. 4, 2006 including prosecution history, including but not limited to Requirement for Restriction/Election dated Jun. 25, 2008 and Non-Final Rejection dated Sep. 4, 2998. |
U.S Appl. No. 11/634,673, filed Dec. 5, 2006 including prosecution history, including but not limited to Requirement for Restriction/Election dated Apr. 9, 2008, Non-Final Rejection dated May 12, 2008, Final Rejection dated Nov. 14, 2008 and Non-Final Rejection dated May 21, 2009. |
U.S. Appl. No. 11/715,057, filed Mar. 6, 2007 including prosecution history, including but not limited to Non-Final Rejection dated Aug. 20, 2008 and Final Rejection dated Apr. 2, 2009. |
Alam, et al., Application of a Zeolite Hemostatic Agent Achieves 100% Survival in a Lethal Model of Complex Groin Injury in Swine, May 2004, The Journal of Trauma Injury, Infection, and Critical Care, vol. 56, pp. 974-983. |
Aldrich—Handbook of Fine Chemicals and Laboratory Equipment, 2000-2001, pp. 1177-1178. |
Analgesics and Anti-inflammatory agents 2004, retrieved from the internet on May 26, 2010, URL: http://web.archive.org/web/20040904151322/http://faculty.weber.edu/ewalker/Medicinal—Chemistry/topics/Analgesia—antiinflam/Analgesics—anti-inflamitory.htm. |
Army halts use of new first aid item to study more, Seattle PI, Dec. 24, 2008. |
Army halts use of WoundStat, http://stripes.com, Apr. 23, 2009. |
Army pulls anti clotting agent after Fort Sam study finds threat, MySanAntonio Military, Dec. 24, 2008. |
Baker, Sarah E. et al., Controlling Bioprocesses with Inorganic Surfaces: Layered Clay Hemostatic Agents, Department of Chemistry and Biochemistry, University of California, Santa Barbara, American Chemical Association 2007, 19, pp. 4390-4392 (3 pages total). |
Basadonna, G., et al.: “A novel kaolin coated surgical gauze improves hemostasis both in vitro and in vivo”, Journal of Surgical Research, vol. 144, No. 2, Feb. 2008, p. 440, XP002534658, abstract. |
Bethesda, MD, TraumaCure, Life-saving News for Battlefield Soldiers & Wounded Civilians FDA Clears Product to Stop Severe Bleeding, Sep. 10, 2007. |
Butenas—Mechanism of factor Vlla-dependent coagulation in hemophilia blood, Hemostasis, Thrombosis, and Vascular Biology, Blood, Feb. 1, 2002—vol. 99, No. 3. |
Carraway, et al., Comparison of a new mineral based hemostatic agent to a commercially available granular zeolite agent for hemostasis in a swine model of lethal extremity arterial hemorrhage, Resuscitation vol. 78, Issue 2, Aug. 2008. |
Clay makers (raw materials) retrieved from the internet on Mar. 15, 2010, URL: http://web.archive.org/web/20020609175053/http://www.claymaker.com/ceramic—central/info/raw—clays.htm (year 2002, pp. 104). |
Comparative Testing of Hemostatic Dressings in a Severe Groin Hemorrhage, Trauma & Resuscitative Medicine Department, NMRC, Aug. 2008. |
Fruijtier-Polloth, “The safety of synthetic zeolites used in detergents”, Arch Toxicol (2009) 83:23-25. |
Galan, et al.: “Technical properties of compound kaolin sample from griva (Macedonia, Greece)”, Applied Clay Science 1996 10:477-490. |
Gibbar-Clements, et al.: “The Challenge of Warfarin Therapy”, JSTOR: The American Journal of Nursing,vol. 100, No. 3 (Mar. 2000), pp. 38-40. |
HemCon Medical Technologies Inc. 501(k) Summary, GhitoGauze, Mar. 20, 2009. |
James, “Silver Copper Zeolite Guinea Pig Sensitization Study—Beuhler Method”, Data Evaluation Report dated Oct. 3, 1989. |
Kheirabadi, Army Assessment of New Hemostatic Products Suitable for Treating Combat Wounds, US Army Institute of Surgical Research, Aug. 11, 2008. |
Kheirabadi, et al., Session IV-B, Paper 28, 8:20 a.m., Comparison of New Hemostatic Dressings with Currently Deployed Hemcon Bandage in a Model of Extremity Arterial Hemorrhage in Swine, Jan. 2009. |
Kheirabadi, et al., The Journal of Trauma Injury, Infection, and Critical Care, Comparison of New Hemostatic Granules/Powders with Currently Deployed Hemostatic Products in a Lethal model of Extremity Arterial Hemorrhage in Swine, Feb. 2009, pp. 316-328. |
Kheirabadi, Final Report, Title: Assessment of Efficacy of New Hemostatic Agents in a Model of Extremity Arterial Hemorrhage in Swine, U.S. Army Institute of Surgical Research, Ft. Sam Houston, TX 78234, Mar. 4, 2008. |
Kovzun, I. G., et al.: “Application of nanosize clay-mineral systems in the complex therapy for hemophilia “A” patients”, Database HCAPLUS [online], XP002534657, retrieved from STN Database accession No. 2009:502758 abstract & Nanosistemi, Nanomateriali, Nanotekhnologii, vol. 6, No. 2, 2008. |
Macrina, VCU's Research Enterprise, Structure and Resources, Oct. 23, 2008. |
Margolis, J., “Initiation of Blood Coagulation by Glass and Related Surfaces,” J. Physiol., 1957, vol. 137, pp. 95-109. |
Margolis, J., The Kaolin Clotting Time: A Rapid One-Stage Method for Diagnosis of Coagulation Defects, J. Clin. Pathol 1958, 11, pp. 406-409 (5 pages total). |
Okada, et al.: “Preparation of zeolite-coated cordierite honeycombs prepared by an in situ crystallization method”, Science and Technology of Advanced Materials 2004 5:479-484. |
O'Reilly et al.: “Studies on Coumarin Anticoagulant Drugs—Initiaion of Warfarin Therapy Without a Loading Dose”, Circulation by the American Heart Association, http://circ.ahajournals.org, 1968, 38, 169-177. |
Ore-Medix, Traumastat Hemostatic Bandage, Aug. 7, 2008. |
Permanent suspension of Woundstat use, https://email.z-medica.com, Apr. 17, 2009. |
Reprinted related contents of US Alaract regarding QuikClot CombatGauze, Sep. 2008. |
Sadler et al.: “Biochemstry and Genetics of Van Willebrand Factor”, Annual Review of Biochemistry; 1998. 67:395-424. |
Scott Sackinger's Medical Devices Professional Summary dated Mar. 2009. |
Sinter. (2004). In the New Penguin Dictionary of Science. London: Penguin. Retrieved May 7, 2009, from http://www.credoreference.com/entry/7463549/. |
Tactical Combat Casualty Care Guidelines, Feb. 2009. |
TraumaCure, Innovative Wound Care Products for Wound Care Solutions, Apr. 24, 2009. |
Vitrify—(2001). In Chambers 21s5t Century Dictionary. London. Chambers Harrap. Retrieved May 7, 2009, from http://www.credoreference.com/entry/1236485/. |
Wagner, Holly, “Topical Oxygen Helps Hard-To-Heal Wounds Heal Faster and Better,” Jan. 28, 2003, obtained from http://researchnews.osu.edu/archive/oxvwound.htm. |
Ward, et al., The Journal of Trauma Injury, Infection, and Critical Care, Comparison of a New Hemostatic Agent to Current Combat Hemostatic Agents in a Swine Model of Lethal Extremity Arterial Hemorrhage, Aug. 2007, pp. 276-284. |
Wound Stat, hhtp://shadowspear.com. |
WoundStat found to be potentially hazardous, http://armytimes.com. |
Wright, J. Barry et al.: “Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment”, American Journal of Infection Control, vol. 26 (6), 1998, pp. 572-577. |
Z-Medica Corporation 510(k) Summary, QuikClot eX, Oct. 4, 2007. |
U.S. Appl. No. 11/054,918, filed Feb. 9, 2005, including prosecution history, including but not limited to Office Action dated Mar. 18, 2008. |
U.S. Appl. No. 12/555,876, filed Sep. 9, 2009, including prosecution history, including but not limited to Office Action dated Dec. 28, 2010 and Office Action dated May 27, 2011. |
U.S. Appl. No. 11/592,477, filed Nov. 2, 2006, including prosecution history, including but not limited to Office Action dated May 28, 2008, Office Action and dated Dec. 22, 2008 and Office Action dated Jun. 18, 2009. |
U.S. Appl. No. 11/643,673, filed Dec. 5, 2006, including prosecution history, including but not limited to Office Action dated May 12, 2008, Office Action dated Nov. 14, 2008, Office Action dated May 21, 2009 and Office Action dated Mar. 25, 2010. |
U.S. Appl. No. 11/590,427, filed Oct. 30, 2006, including prosecution history, including but not limited to Office Action dated Aug. 19, 2008, Office Action dated May 26, 2009, Office Action dated Jun. 7, 2010 and Office Action dated Apr. 5, 2011. |
U.S. Appl. No. 12/417,802, filed Apr. 3, 2009, including prosecution history, including but not limited to Office Action dated Jun. 11, 2010 and Office Action dated Jan. 25, 2011. |
U.S. Appl. No. 11/633,687, filed Dec. 4, 2006, including prosecution history, including but not limited to Office Action dated Sep. 4, 2008 and Office Action dated Jun. 12, 2009. |
U.S. Appl. No. 11/654,409, filed Jan. 17, 2007, including prosecution history, including but not limited to Office Action dated Mar. 30, 2010 and Final Office Action dated Oct. 25, 2010. |
U.S. Appl. No. 11/715,057, filed Mar. 6, 2007, including prosecution history, Including but not limited to Non-Final Rejection dated Aug. 20, 2008 and Final Rejection dated Apr. 2, 2009. |
U.S. Appl. No. 12/581,782, filed Oct. 19, 2009, including prosecution history, including but not limited to Office Action dated Mar. 16, 2011. |
U.S. Appl. No. 10/939,869, filed Sep. 13, 2004, including prosecution history, including but not limited to Office Action dated Feb. 8, 2008, Office Action date Sep. 17, 2008, Final Office Action dated Apr. 17, 2009, Final Office Action dated Apr. 1, 2010, Final Office Action date Dec. 12, 2010 and Office Action dated May 17, 2011. |
U.S. Appl. No. 11/082,716, filed Mar. 16, 2005, including prosecution history, including but not limited to Office Action dated Oct. 9, 2008. |
U.S. Appl. No. 11/303,607, filed Dec. 16, 2005, including prosecution history, including but not limited to Office Action dated Apr. 29, 2008 and Office Action dated Sep. 8, 2008. |
U.S. Appl. No. 11/404,126, filed Apr. 13, 2006, including prosecution history, including but not limited to Office Action dated Dec. 3, 2008, Office Action dated Dec. 21, 2009 and Notice of Abandonment dated Oct. 8, 2010. |
U.S. Appl. No. 11/586,986, filed Oct. 25, 2006, including prosecution history, including but not limited to Office Action dated Feb. 19, 2010 and Office Action dated Jun. 3, 2010. |
U.S. Appl. No. 10/939,687, filed Sep. 13, 2004, Including prosecution history. |
U.S. Appl. No. 11/023,869, filed Dec. 27, 2004, including prosecution history, including but not limited to Office Action dated May 12, 2008, Office Action dated Dec. 11, 2008, Office Action dated Jan. 26, 2010 and Office Action dated Sep. 16, 2010. |
U.S. Appl. No. 11/606,617, filed Nov. 29, 2006, including prosecution history, including but not limited to Office Action dated Jun. 12, 2009. |
U.S. Appl. No. 11/710,106, filed Feb. 22, 2007, including prosecution history, including but not limited to Office Action dated Oct. 1, 2010. |
U.S. Appl. No. 12/101,336, filed Apr. 11, 2008, including prosecution history, including but not limited to Office Action dated Mar. 22, 2010 and Notice of Abandonment dated Oct. 7, 2010. |
U.S. Appl. No. 12/101,346, filed Apr. 11, 2008, including prosecution history, including but not limited to Office Action dated Mar. 19, 2010 and Office Action dated Sep. 15, 2010. |
U.S. Appl. No. 12/140,356, filed Jun. 17, 2008, including prosecution history, including but not limited to Office Action dated Sep. 28, 2010 and Office Action dated Mar. 21, 2011. |
U.S. Appl. No. 12/204,129, filed Sep. 4, 2008, including prosecution history, including but not limited to Office Action dated May 31, 2011. |
U.S. Appl. No. 11/544,238, filed Oct. 6, 2006, including prosecution history, including but not limited to Office Action dated May 29, 2009 and Office Action dated Jun. 25, 2010. |
U.S. Appl. No. 12/503,481, filed Jul. 15, 2009, including prosecution history, including but not limited to Office Action dated Dec. 27, 2010 and Office Action dated Jul. 5, 2011. |
U.S. Appl. No. 13/175,380, filed Jul. 1, 2011 including prosecution history. |
Angeloni, V., M.D.: “How to care for your wound,” Heartland Dermatology & Skin Cancer P. C., copyright 2001, V. Angeloni MD. |
U.S. Appl. No. 11/634,531, filed Dec. 6, 2006, including prosecution history, including but not limited to Office Action dated Feb. 4, 2009; Office Action dated Sep. 4, 2009, Office Action dated Mar. 29, 2010; Final Office Action dated Oct. 5, 2010; Office Action dated Jun. 23, 2011; BPAI Notice of Appeal dated Apr. 17, 2012, Appeal No. 2012-007306. |
U.S. Appl. No. 12/204,129, filed Sep. 4, 2008, including prosecution history, including but not limited to Office Action dated May 31, 2011, Nov. 17, 2011, and Notice of Abandonment dated Jun. 20, 2012. |
U.S. Appl. No. 12/555,876, filed Sep. 9, 2009, including prosecution history, including but not limited to Office Action dated Dec. 28, 2010, Office Action dated May 27, 2011, and Notice of Allowance dated Jun. 14, 2012. |
U.S. Appl. No. 13/115,699, filed May 25, 2011 including prosecution history, including but not limited to Notice of Allowance dated May 30, 2012. |
U.S. Appl. No. 13/526,431, filed Jun. 18, 2012 including prosecution history. |
U.S. Appl. No. 10/939,869, filed Sep. 13, 2004, including prosecution history, including but not limited to Final Office Action dated May 17, 2011. |
U.S. Appl. No. 12/140,356, filed Jun. 17, 2008, including prosecution history, including but not limited to Final Office Action dated Mar. 21, 2011. |
U.S. Appl. No. 11/584,079, filed Oct. 20, 2006, including prosecution history, including but not limited to Office Action dated Apr. 6, 2009. |
U.S. Appl. No. 11/634,673, filed Dec. 5, 2006, including prosecution history, including but not limited to Office Action dated Nov. 14, 2008. |
U.S. Appl. No. 12/417,802, filed Apr. 3, 2009, including prosecution history, including but not limited to Office Action dated Jun. 11, 2010. |
Webster's Dictionary definition of “expose” (1993). |
U.S. Appl. No. 13/911,616, filed Jun. 6, 2013, including prosecution history. |
Comparative Testing of Hemostatic Dressings in a Severe Groin Hemorrhage, Trauma & Resuscitative Medicine Department, NMRC, Aug. 2008 (Part 1 of 3, pp. 1-9). |
Comparative Testing of Hemostatic Dressings in a Severe Groin Hemorrhage, Trauma & Resuscitative Medicine Department, NMRC, Aug. 2008 (Part 2 of 3, pp. 10-19). |
Comparative Testing of Hemostatic Dressings in a Severe Groin Hemorrhage, Trauma & Resuscitative Medicine Department, NMRC, Aug. 2008 (Part 3 of 3, pp. 20-29). |
U.S. Appl. No. 13/240,795, filed Sep. 22, 2011, including prosecution history. |
U.S. Appl. No. 13/682,085, filed Nov. 20, 2012, including prosecution history. |
Connor, William E.: “The Acceleration of Thrombus Formatin by Certain Fatty Acids,” Journal of Clinical Investigation, vol. 41, No. 6, 1962. |
Hubbard, et al.: “Ionic charges of glass surfaces and other materials, and their possible role in the coagulation of blood,” Journal of Applied Physiology, Mar. 1, 1960, vol. 15, No. 2, pp. 265-270. |
Ross, et al., “The Kaolin Minerals,” J. Amer. Ceramic Soc., vol. 13, issue 3, pp. 151 to 160, Mar. 1930. |
Curasorb Calcium Alginate Dressings information page, http://www.kendallhq.com/kendallhealthcare/pageBuilder.aspx?webPageID=0&topicID=70966&xsl=xsl/productPagePrint.xsl (last accessed May 22, 2012). |
Hollister Wound Care Restor Calcium Alginate Dressing, Silver instruction manual and information booklet, available at http://hollisterwoundcare.com/files/pdfs/ifus/Restore907814B407ColorBreak.pdf (last accessed May 22, 2012). |
Medline Maxorb Extra AG Silver Alginate, http://www.medicaldepartmentstore.com/Medline-Maxorb-p/1560.htm (last accessed May 22, 2012). |
“Mastering the Art of Innovative Thinking,” (color brochure) FMC BioPolymer, 2001 FMC Corporation. |
Davis et al., 1H—NMR Study of Na Alginates Extracted from Sargassum spp. in Relation to Metal Biosorption, 110 Applied Biochemistry and Biotechnology 75 (2003). |
Hahn, Lynn: “High temperature 1H NMR to determine the relative amounts of guluronate and mannuronate in the sodium alginate sample”, Intertek, ASA, Analytical Report, Report No. 60665 v 1, dated May 6, 2012. |
Manugel® GMB alginate, FMC BioPolymer, Know how. It works.sm Product Specifications, 2011 FMC Corporation. |
U.S. Appl. No. 10/939,869, filed Sep. 13, 2004 including prosecution history, including but not limited to Non-Final Rejection dated Feb. 8, 2008, Non-Final Rejection dated Sep. 17, 2008, Final Rejection dated Apr. 17, 2009, Final Office Action dated Apr. 1, 2010, Final Office Action dated Dec. 12, 2010; Final Office Action dated May 17, 2011 and Notice of Allowance dated Mar. 23, 2012. |
U.S. Appl. No. 13/922,115, filed Jun. 19, 2013, including prosecution history. |
EPO Extended Search Report, re EP Application No. 12163455, dated Sep. 12, 2012. |
Lin et al., Synthesis of Hybridized Polyacrylic Acid-Kaolin Material and Its Superwater Absorbent Performance, J. Huaqiao Univ. (Nat. Sci.) Mar. 2000. |
Long et al., Synthesis of Bentonite-superabsorbent Composite, J. Guilin Inst. Tech., Feb. 2004. |
U.S. Appl. No. 13/593,310, filed Aug. 23, 2012, including prosecution history. |
U.S. Appl. No. 13/595,932, filed Aug. 27, 2012, including prosecution history. |
U.S. Appl. No. 13/598,381, filed Aug. 29, 2012, including prosecution history. |
Dictionary of Traditional Chinese Medicine, “Astringents and Haemostatices,” The Commercial Press, Ltd., Apr. 1984 [ISBN 962 07 3051 8], pp. 216-217, total 4 pages. |
Hempen, et al., A Materia Medica for Chinese Medicine, Plants minerals and animal products, Churchill Livingston Elsevier, 2009, [ISBN 978 0 443 10094 9], pp. 832-833 (Halloysitum rubrum, Chi shi zi), total 5 pages. |
Hsu, et al. Orintal Materia Medica—a concise guide, pp. 310-311, 612-613, 32-34, total 12 pages. Oriental Healing Arts Institute, 1986. [ISBN 0 941 942 22 8]. |
Huang, Pharmacology of Chinese Herbs, Second Edition, p. 243 (Antidiarrheal Herbs), total 3 pages. CRC Press 1999. [ISBN 0 8493 1665 0]. |
Li; et al. Chinese Materia Medica—Combinations and Applications, Donica Publishing Ltd., 2002, [ISBN 1 901149 02 1], p. 622 (Ch. 18 Herbs for Promoting Astriction), total 5 pages. |
Soine et al., Roger's Inorganic Pharmaceutical Chemistry, Lea & Febiger 1967, p. 462-463 (Aluminum and Aluminum Compounds), [QV744 S683r 1967] total 5 pages. |
Wu, Jing-Nuan, “An Illustrated Chinese Materia Medica,” Oxford University Press, Inc. 2005 (13 pages). |
Xinrong, Traditional Chinese Medicine, A Manual from A-Z, Symptoms, Therapy and Herbal Remedies, [ISBN 3 540 42846 1], p. 470 (total 3 pages), Springer-Verlag Berlin Heidelberg 2003. |
Yanchi, The Essential Book of Traditional Chinese Medicine, vol. 2: Clinical Practice, p. 155-157 (Traditional Chinese Prescriptions), , 142-143 (Chinese Medicinal Herbs) total 8 pages. [ISBN 0 231 06518 3 9v.2] 1988. |
U.S. Appl. No. 13/759,963, filed Feb. 5, 2013, including prosecution history. |
Angeloni, V., M.D.: “How to care for your wound.”, Heartland Dermatology & Skin Cancer P. C., copyright 2001, V. Angeloni MD. |
CA Office Action re Application No. 2,590,595, filed Dec. 22, 2005, Office Action dated Apr. 17, 2009. |
CA Office Action re Application No. 2,677,606 filed Mar. 6, 2008, Office Action dated Jan. 26, 2012. |
CA Office Action re Application No. 2,677,606 filed Mar. 6, 2008, Office Action dated Sep. 30, 2011. |
Caloplast (Kaoline Poultrice), South African Electronic Package Inserts, Information presented by Malahyde Information Systems, Copyright 1996-1998, printed from home.intekom.com/pharm/allied/caloplst.html#INDICATIONS, two pages. |
EPO Examination Report re EP 1 663 090, dated Dec. 8, 2011. |
Griffin, John H., Role of surface in surface-dependent activation of Hageman factor (blood coagulation Factor XII), Proc. Natl. Acad. Sci. USA, vol. 75, No. 4, Apr. 1978, pp. 1998-2002 (5 pages total). |
PCT International Search Report re Application No. PCT/US2010/041741, dated Nov. 26, 2010. |
Reprinted related contents of U.S. Abstract regarding quickclot Combat Gauze (reprinted May 21, 2009). |
Vlok, Marie E.: “Kaoline poultice”, Manual of Nursing, vol. 1, Basic Nursing, revised ninth edition, p. 269. Copyright Juta & Co, Ltd., Lansdowne, South Africa, first published 1962. |
Wound Stat, http://shadowspear.com/vb/showthread.php?t=16586 dated Dec. 22, 2008, last accessed Apr. 16, 2009. |
WoundStat found to be potentially hazardous, Army News, news from Iraq . . . , http://armytimes.com/news/2009/04/army—woundstat—042009w/, posted Apr. 20, 2009, last accessed Apr. 20, 2009. |
U.S. Appl. No. 12/352,513, filed Jan. 12, 2009 including prosecution history. |
U.S. Appl. No. 11/592,477, filed Nov. 2, 2006 including prosecution history, including but not limited to Non-Final Rejection dated May 28, 2008 and Final Rejection dated Dec. 22, 2008, Office Action dated Jun. 18, 2009 and Notice of Allowance dated Mar. 6, 2012. |
U.S. Appl. No. 11/634,531, filed Dec. 6, 2006, including prosecution history, including but not limited to Office Action dated Feb. 4, 2009; Office Action dated Sep. 4, 2009, Office Action dated Mar. 29, 2010; Final Office Action dated Oct. 5, 2010; Office Action dated Jun. 23, 2011. |
U.S. Appl. No. 12/204,129, filed Sep. 4, 2008, including prosecution history, including but not limited to Office Action dated May 31, 2011 and Nov. 17, 2011. |
U.S. Appl. No. 12/510,203, filed Jul. 27, 2009, including prosecution history, including but not limited to, Office Action dated Sep. 26, 2011 and Feb. 24, 2012. |
U.S. Appl. No. 12/611,830, filed Nov. 3, 2009, including prosecution history, including but not limited to Office Action dated Nov. 4, 2011 and Notice of Allowance dated Feb. 1, 2012 . |
U.S. Appl. No. 60/668,022, filed Apr. 4, 2005, including prosecution history. |
U.S. Appl. No. 60/708,206, filed Aug. 15, 2005, including prosecution history. |
U.S. Appl. No. 60/902,738, filed Feb. 21, 2007, including prosecution history. |
U.S. Appl. No. 60/955,854, filed Aug. 14, 2007, including prosecution history. |
US Final Office Action re U.S. Appl. No. 10/939,869, filed Sep. 13, 2004, Office Action dated May 17, 2011. |
US Office Action (Final) re U.S. Appl. No. 12/140,356, filed Jun. 17, 2008, Office Action dated Mar. 21, 2011. |
US Office Action re U.S. Appl. No. 11/584,079, filed Oct. 20, 2006, Office Action dated Apr. 6, 2009. |
US Office Action re U.S. Appl. No. 11/634,673, filed Dec. 5, 2006, Office Action dated Nov. 14, 2008. |
US Office Action re U.S. Appl. No. 12/417,802, filed Apr. 3, 2009, Office Action dated Jun. 11, 2010. |
Number | Date | Country | |
---|---|---|---|
20070251849 A1 | Nov 2007 | US |
Number | Date | Country | |
---|---|---|---|
60796121 | Apr 2006 | US |